Overexpression of IDO in endometrial cancer cells may contribute to tumor development in vivo by inhibiting NK cell activity to exert an immunosuppressive effect (Zhan et al., 2020), suggesting that IDO is a novel and reliable prognostic indicator for endometrial cancer. This evidence concerns the gene IDO1 and endometrial cancer.